Top Story

Houston first US city to join Cities Changing Diabetes program

November 23, 2014

A partnership was recently announced between the city of Houston and Novo Nordisk to fight the urban diabetes epidemic, according to a company press release.

The Cities Changing Diabetes program was initiated early in 2014 by Novo Nordisk and Houston is the third city globally and the first in the United States to join the program.

First US bariatric embolization procedure performed

November 22, 2014
The first US bariatric embolization was recently performed by physicians at Dayton Interventional Radiology, according to a press release from the institution.The…
In the Journals

Lung transplant increased risk for dysglycemia, new-onset diabetes

November 21, 2014
In the first year after undergoing a lung transplant, most patients experience dysglycemia and may also be at significant risk for new-onset diabetes, according to…
Meeting News Coverage

BMI cited as poor predictor of early complications after TJA

November 21, 2014
DALLAS — Results of a database review study presented here indicated a correlation between increased body mass index and 30-day complications for total joint…
In the Journals

Mobile telehealth program helped shift behavior in patients with diabetes

November 21, 2014
Behaviorally driven telephone health interventions can be used to address several pathways associated with sustained lifestyle change in patients with diabetes…
More News Headlines »
CME
Experts Take: Dialogue on HTG

Experts’ Take: Dialogue on Hypertriglyceridemia

This activity is supported by an independent educational grant from Amarin Pharma Inc.

Lead by genetic studies, recent data describe a causal role of triglycerides (TG) in the formation of atherosclerosis…
More »
Meeting News Coverage Video
thumbnail for video 3886443649001

Risk stratification guidelines help determine treatment for thyroid cancer

November 11, 2014
Fabian Pitoia, MD,  head of the thyroid section of the division of endocrinology at the Hospital de Clinicas of…
More »
CME
Treatment of Acromegaly: Current Options - Part 3 of 5

Treatment of Acromegaly: Emerging Options - Part 4 of 5

This activity is supported by an educational grant from Genentech.

Several medical therapies for acromegaly, including somatostatin receptor agonists, dopamine receptor agonists, and a…
More »
morganatic-roan